The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001204.7(BMPR2):c.1087C>G (p.Leu363Val)

CA2061285

1309924 (ClinVar)

Gene: BMPR2
Condition: pulmonary arterial hypertension
Inheritance Mode: Autosomal dominant inheritance
UUID: af39a3f7-9f0a-4422-befe-2a231862a790
Approved on: 2024-04-30
Published on: 2024-04-30

HGVS expressions

NM_001204.7:c.1087C>G
NM_001204.7(BMPR2):c.1087C>G (p.Leu363Val)
NC_000002.12:g.202530913C>G
CM000664.2:g.202530913C>G
NC_000002.11:g.203395636C>G
CM000664.1:g.203395636C>G
NC_000002.10:g.203103881C>G
NG_009363.1:g.159587C>G
ENST00000374580.10:c.1087C>G
ENST00000638587.1:c.1018C>G
ENST00000374574.2:c.1087C>G
ENST00000374580.8:c.1087C>G
NM_001204.6:c.1087C>G

Uncertain Significance

Met criteria codes 3
BP4 PM1 PM2
Not Met criteria codes 5
BA1 BS1 BS2 PP3 PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Pulmonary Hypertension Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for BMPR2 Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Pulmonary Hypertension VCEP
The BMPR2 c.1087C>G is a missense variant predicted to cause substitution of leucine to valine at amino acid position 363 ((p.(Leu363Val)). This variant is absent from gnomAD version2.1.1 controls and v3.1.2 (PM2_supporting met). The variant resides in the highly conserved protein kinase domain without functional evidence for a critical or non-critical role on protein function (PM1 met). The variant is predicted to have no effect on protein function with REVEL score of 0.24, which meets the threshold for BP4 (<0.25). There is another individual with the same variant in ClinVar but with insufficient evidence for a pulmonary arterial hypertension diagnosis. In summary, the variant meets the criteria to be classified as a variant of unknown significance (VUS) for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PM2_supporting, PM1, BP4 (VCEP specification version 1.1, 1/18/2024).
Met criteria codes
BP4
REVEL score is 0.24
PM1
Variant resides within the highly conserved protein kinase domain (aa.203-504). There is no functional data available specifying whether the residue is critical or not critical to protein function.
PM2
Variant is absent from gnomAD v2.1.1 controls and v3.1.2
Not Met criteria codes
BA1
Variant is absent from gnomAD v2.1.1 controls and v3.1.2
BS1
Variant is absent from gnomAD v2.1.1 controls and v3.1.2
BS2
Variant was not observed as a homozygous allele in gnomAD v2.1.1 controls.
PP3
REVEL score is 0.24
PS4
There is another individual with the same variant in ClinVar but with insufficient evidence for a pulmonary arterial hypertension diagnosis.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.